Literature DB >> 4383857

Blood concentrations of pethidine and pentazocine in mother and infant at time of birth.

A H Beckett, J F Taylor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4383857

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  9 in total

Review 1.  Pentazocine: a review of its pharmacological properties, therapeutic efficacy and dependence liability.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of narcotic agonist-antagonist drugs.

Authors:  R E Bullingham; H J McQuay; R A Moore
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

Review 3.  Plasma protein binding of drugs in pregnancy.

Authors:  E Perucca; A Crema
Journal:  Clin Pharmacokinet       Date:  1982 Jul-Aug       Impact factor: 6.447

Review 4.  Drug kinetics in childbirth.

Authors:  R L Nation
Journal:  Clin Pharmacokinet       Date:  1980 Jul-Aug       Impact factor: 6.447

5.  Placental transfer of pethidine and norpethidine and their pharmacokinetics in the newborn.

Authors:  P L Morselli; V Rovei
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

6.  Elimination of pethidine and bupivacaine in the newborn.

Authors:  L V Cooper; G W Stephen; P J Aggett
Journal:  Arch Dis Child       Date:  1977-08       Impact factor: 3.791

Review 7.  Clinical pharmacokinetics of pethidine.

Authors:  L E Mather; P J Meffin
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

8.  Maternal kinetics and transplacental passage of pethidine during labour.

Authors:  G Tomson; R I Garle; B Thalme; H Nisell; L Nylund; A Rane
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

9.  Prenatal and neonatal drug metabolism in man.

Authors:  A Rane; G Tomson
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.